Clinical Research Directory

Inclusion Criteria: * A glycated hemoglobin (HbA1c) level of \<5.7% at Screening * A 12-lead electrocardiogram (ECG) at Screening which, in the opinion of the Investigator, had no abnormalities that compromised safety in this study * Hematology, clinical chemistry and urinalysis at Screening, the results of which fall within normal parameter ranges and/or are deemed clinically acceptable by the Investigator Exclusion Criteria * Males and nonpregnant, nonlactating females Exclusion Criteria: * Any prior use of or contraindication to atypical antipsychotics * Concomitant use of drugs known to impact the PK of olanzapine * Type 1 or Type 2 diabetes * Recent CV event * Uncontrolled hypertension * Fasting triglycerides ≥400 mg/dL * Fasting glucose ≥100 mg/dL * Any condition that impacts the absorption of dietary fats * Significant gastrointestinal disorders * Gall bladder disease * Uncontrolled hypothyroidism * Liver disease or dysfunction * Renal disease or dysfunction * Gastrointestinal conditions * Hematologic disorders * Active malignancy * Psychiatric disorder * History of drug or alcohol abuse * Pregnant, breastfeeding, or intending to become pregnant * Use of weight loss products * Blood donation or loss within 30 days prior to Screening